|
Oren Barmapov in the Andes Mountains in Machu Picchu in 2008 (photo by Michelle) |
|
“Autism has been an area that I have dedicated much of my adult life. Some people have asked me why I got into autism and it was originally due to my working with an autistic student when I had just graduated from University. This student had such an impact on my life. I was always trying to find new methods to teach him. It was at this time that I dedicated my career to autism. When I met my husband Oren, I came to learn more about Crohn’s Disease. It is a very difficult disease to live with however with proper treatments, and a wonderful attitude towards life (my husband’s), you can still live a fulfilling life. I share this page with you as it is a disease that directly affects our family and I want people to become more informed.” |







|
Founder of the blended method of Montessori and Applied Behaviour Analysis for children with autism. |
|
CROHN’s |
|
Submitted by admin on Wed, 2006-07-26 07:00. :: The disease -- affecting one in 200 Canadians, one of the highest rates in the world -- is an inflammation of the bowel that can lead to severe symptoms, including pain, diarrhea, weight loss and fatigue. "There are times you feel great," Barmapov said. "When you feel great, you want to do everything. Then overnight, you can take a turn for the better or worse." "So far, right now, I've been great," said Barmapov, who works in accounting. "It seems every few years, something jumps up ... It's always in the back of your mind -- when's the next episode." It's a complex disease and "it's a very difficult one to develop a new drug (for)," said Dr. Dilip Patel, chief of the division of gastroenterology at Ottawa Hospital. There is no cure for Crohn's. There is only one treatment for the 40,000 Canadians with moderate to severe Crohn's -- a drug administered by IV generally every eight weeks which is expensive and isn't effective in every patient. Remicade costs about $4,000 an injection, although it is generally covered in whole or part by drug plans. |